SolAeroMed is the leader in biophysical
respiratory drugs and delivery devices.

Learn More


Asthma Rescue Drug & Delivery Device
In Phase II Clinical Trials


Surfactant Dysfunction
In Pre-Clinical Development

Sleep Apnea Device

Treats apneas
In Pre-Clinical Development

About SolAeroMed

SolAeroMed is a company dedicated to the development of novel therapeutic strategies to treat obstructive lung diseases. Our lead asthma drug, S-1226, is in Phase II clinical trials designed to demonstrate Proof of Concept.

For more information, please see our Business Presentation.


SolAeroMed Annual General Meeting
Join us at our AGM.
Date: June 30, 2015
Time: 4pm – 6pm
Location: SolAeroMed offices
(3535 Research Road NW, Calgary)

SolAeroMed is seeking development partners for their
novel Asthma, Surfactant Dysfunction, and Sleep Apnea products.

Learn More